Rija Siddiqui
Psychiatry · Dallas, TXNPI 1093169716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,657, 6.4 times the $413 reported in 2023.
Across 205 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$827
- Neurocrine Biosciences, Inc.$569
- AbbVie$443
- Validus Pharmaceuticals LLC$385
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$381
- Lundbeck LLC$377
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,782100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 30 | $827 |
| Neurocrine Biosciences, Inc. | 14 | $569 |
| AbbVie | 32 | $443 |
| Validus Pharmaceuticals LLC | 7 | $385 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $381 |
| Lundbeck LLC | 19 | $377 |
| Otsuka America Pharmaceutical, Inc. | 16 | $260 |
| Axsome Therapeutics, Inc. | 5 | $226 |
| Alkermes, Inc. | 8 | $195 |
| Vanda Pharmaceuticals Inc. | 7 | $180 |
| E.r. Squibb & Sons, L.L.C. | 10 | $164 |
| Almatica Pharma LLC | 7 | $160 |
| Teva Pharmaceuticals USA, Inc. | 6 | $114 |
| Johnson & Johnson | 4 | $72 |
| Bausch Health US, LLC | 3 | $54 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Neos Therapeutics, LP | 3 | $45 |
| Noven Therapeutics, LLC | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 2 | $33 |
| Livanova USA, Inc. | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Tris Pharma Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,794 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Madhukar TrivediDallas$209K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.